Finding out you have cancer is scary enough. But if the doctor says it's stage 4 then you know it's life-threatening. See how a nationwide study changed the life of one woman who was told she was ready for hospice.
Anita Shangvi has battled breast cancer since 2007.
Shangvi said, "First recurrence was 2011."
Then three years ago she found out the cancer had spread.
Shangvi continued, "It went to the lungs and I was shot into stage 4."
Carmen Calfa, MD, Breast Medical Oncologist, Assistant Professor of Clinical Medicine, and Associate Director of Community Outreach Breast Cancer Program at Sylvester Comprehensive Cancer Center in Plantation says the problem is when standard treatments stop working.
"So, patients go through several lines of therapy because what happens is cancer outsmarts us unfortunately," said Dr. Calfa.
Now there's hope for stage 4 cancer patients who've run out of treatment options. It's called the TAPUR study.
Dr. Calfa explained, "So it's basically using a drug that has an FDA approval for a different cancer type."
Study participants go through genomic testing to determine the specific mutation of their tumor. The study then matches the patient to a targeted therapy already on the market for a different cancer.
"It will look to see if it's efficacious, if it works, if it's safe, what are your side effects," said Dr. Calfa.
Shangvi qualified for the study and is now getting an investigational therapy for her metastatic breast cancer.
Shangvi said, "Fourteen months later I'm here talking to you guys!"
Shangvi gets an infusion every three weeks. She's still in the battle of her life but now feels she's got a fighting chance.
"It has given me that optimism, it has put me back in the game. And you know what, I have a chance here," said Shangvi.
Allowing daughter Tasha to spend more time with her mom.
Health Watch: TAPUR: When chemo stops working
More TOP STORIES News